Streetbeat News

CANN

Trees Corporation.

http://www.generalcann.com/

CEO

Steve Gutterman

Employees

77

Industry

Other Activities Related to Real Estate

Open

0.03

Mkt cap

3.1M

Volume

200

High

0.03

P/E Ratio

-0.57

52-wk high

0.13

Low

0.03

Div yield

N/A

52-wk low

0.01

Heritage Cannabis Holdings Corp. (HERTF) announced it has sought creditor protection under the Companies Creditors Arrangement Act, due to financial difficulties. The company has entered into agreements to sell its real estate properties, aiming to reduce its term debt by approximately 64%. Despite a slight decrease in fourth-quarter revenue, Heritage reported a significant increase in gross margin. However, its shares plunged 76.67% following the announcement.

Portfolio Pulse from Jelena Martinovic

April 03, 2024 | 7:06 pm

Heritage Cannabis Holdings Corp. (OTCQB:HERTF) reported a significant increase in gross margin for 2023, with over 50% for the year and 628% for Q4 compared to last year. CEO David Schwede attributed this success to product optimization, production efficiencies, and high gross margin sales. The company's products, including RAD vape and Adults Only brand, remain in high demand, particularly in New York, Missouri, and West Virginia. Despite a slight drop in net revenue for Q4 2023, the company saw a decrease in comprehensive loss and general and administrative expenses, indicating improved financial health.

Portfolio Pulse from Jelena Martinovic

February 27, 2024 | 5:10 pm

Cannabis stocks experienced significant movements on February 7, 2024, with ESCO Technologies leading the gainers with an unprecedented rise. The sector saw a mix of sharp increases and declines among various companies, indicating a volatile market environment for cannabis-related stocks.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 9:30 pm

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 2, 2024, with notable gainers including Tony G Co-Investment, Global Hemp Group, and Khiron Life Sciences. On the downside, Global Compliance, MJ Holdings, and Rocky Mountain High were among the top losers. Neptune Wellness Solutions, Eastside Distilling, Canopy Growth, cbdMD, Corbus Pharmaceuticals, Tilray Brands, and Cronos Group were notable companies listed on major exchanges that saw price changes.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 1, 2024, with notable gainers including EVIO, Australis Capital, and OrganiGram Holdings, among others. EVIO led with a 9900.00% increase. On the downside, Rhinomed, Khiron Life Sciences, and Item 9 Labs were among the top losers. This reflects a volatile day in the cannabis sector, impacting several US-listed companies such as OrganiGram Holdings (OGI), Psychemedics (PMD), Cronos Group (CRON), Tilray Brands (TLRY), Canopy Growth (CGC), Eastside Distilling (EAST), 22nd Century Group (XXII), Greenlane Holdings (GNLN), SNDL Inc. (SNDL), and Aurora Cannabis (ACB).

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

The article reports on the significant price movements of various cannabis-related stocks on January 30, 2024. Notable gainers include MedMen Enterprises, EVIO, Corbus Pharmaceuticals, and others, with MedMen and EVIO both closing up 9900.00% at $0.0001. On the losing side, Rhinomed led the declines with a 73.54% drop. The article lists both gainers and losers with their respective percentage changes and closing prices.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 9:30 pm

The article reports on the significant price movements of various marijuana stocks on January 29, 2024. Notable gainers include CordovaCann, Blueberries Medical, and 1933 Industries, with increases of 26.53%, 26.14%, and 15.88% respectively. Psychemedics, 4Front Ventures, and Canopy Growth also saw gains. On the losing side, EVIO plummeted by 99%, while Global Hemp Group and Corbus Pharmaceuticals experienced significant drops of 45.30% and 34.93%. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 9:30 pm

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.